Switch to:
Haemonetics Corp (NYSE:HAE)
Research and Development
$51.0 Mil (TTM As of Dec. 2015)

This is the expense the company spent on research and development. Haemonetics Corp's research and development for the three months ended in Dec. 2015 was $10.9 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2015 was $51.0 Mil.


Definition

This is the expense the company spent on research and development.

Haemonetics Corp Research & Development for the trailing twelve months (TTM) ended in Dec. 2015 was 17.225 (Mar. 2015 ) + 11.321 (Jun. 2015 ) + 11.553 (Sep. 2015 ) + 10.942 (Dec. 2015 ) = $51.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Haemonetics Corp Annual Data

Mar07Mar08Mar09Mar10Mar11Mar12Mar13Mar14Mar15Mar16
Research & Development 23.924.323.926.432.736.844.454.254.245.6

Haemonetics Corp Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
Research & Development 14.213.815.410.910.617.211.311.610.911.7
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK